Clinuvel Pharmaceuticals Limited (CUVL)
NASDAQ: CUVL · Real-Time Price · USD
5.95
-0.21 (-3.41%)
Aug 31, 2026, 4:00 PM EDT - Market closed
Clinuvel Pharmaceuticals Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 94.02 | 94.02 | 95.02 | 88.18 | 78.32 | 65.72 |
Revenue Growth | -2.37% | -1.04% | 7.76% | 12.58% | 19.17% | 36.02% |
Gross Profit Gross Profit Growth | 78.21 | 78.21 | 80.2 | 80.45 | 70.8 | 56.47 |
Operating Income Operating Income Growth | 40.53 | 40.53 | 41.27 | 48.57 | 44.13 | 35.55 |
Net Income Net Income Growth | 33.92 | 33.92 | 36.17 | 35.64 | 30.6 | 20.88 |
Earnings Per Share EPS Growth | 0.67 | 0.67 | 0.72 | 0.70 | 0.59 | 0.40 |
EPS Growth | 3.78% | -6.96% | 2.86% | 18.11% | 46.65% | -16.74% |
Revenue by Geography
| Fiscal Year | TTM | FY 2026 | FY 2025 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 |
Ireland Ireland Growth | 52.51 | 52.51 | 46.21 |
United States United States Growth | 40.73 | 40.73 | 47.91 |
Rest of The World Rest of The World Growth | 0.79 | 0.79 | 0.9 |
Total Total Growth | 94.02 | 94.02 | 95.02 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 252.06 | 252.06 | 224.11 | 183.87 | 156.81 | 121.51 |
Total Debt Total Debt Growth | 1.94 | 1.94 | 0.53 | 0.88 | 1 | 1.26 |
Net Cash (Debt) Net Cash Growth | 250.12 | 250.12 | 223.58 | 182.99 | 155.81 | 120.25 |
Net Cash Growth | 7.50% | 11.87% | 22.18% | 17.44% | 29.57% | 47.75% |
Net Cash Per Share Net Cash Per Share Growth | 4.93 | 4.93 | 4.44 | 3.59 | 3.01 | 2.32 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 36.91 | 36.91 | 41.1 | 37.05 | 36.91 | 39.87 |
Capital Expenditures CapEx Growth | -1.6 | -1.6 | -0.3 | -5.58 | -1.03 | -0.43 |
Free Cash Flow Free Cash Flow Growth | 35.31 | 35.31 | 40.8 | 31.48 | 35.88 | 39.44 |
Free Cash Flow Growth | -11.90% | -13.46% | 29.61% | -12.28% | -9.01% | 114.25% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 83.18% | 83.18% | 84.41% | 91.23% | 90.40% | 85.92% |
Operating Margin | 43.11% | 43.11% | 43.43% | 55.08% | 56.34% | 54.09% |
Pretax Margin | 50.69% | 50.69% | 54.26% | 57.47% | 58.19% | 52.22% |
Profit Margin | 36.07% | 36.07% | 38.07% | 40.41% | 39.08% | 31.77% |
FCF Margin | 37.55% | 37.55% | 42.94% | 35.70% | 45.82% | 60.01% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 1, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.029 | 0.050 | 0.050 | 0.050 | 0.050 | 0.040 |
Dividend Per Share Growth | 8.73% | 0% | 0% | 0% | 25.00% | 60.00% |
Dividend Yield | 0.48% | 0.47% | 0.48% | 0.34% | 0.28% | 0.27% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 1, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 12.34 | 15.28 | 14.38 | 21.60 | 28.87 | 35.14 |
P/FCF Ratio | 11.44 | 14.68 | 12.75 | 24.46 | 24.62 | 18.61 |
PS Ratio | 4.45 | 5.51 | 5.48 | 8.73 | 11.28 | 11.16 |